Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)

Aún no traducido Aún no traducido
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2002
Cargando información sobre las referencias
The purpose of thie study is to evaluate the safety, tolerability, immunogenicity, pharmacokinetics and pharmacodynamics of belimumab (LymphoStat-B™)in subjects with SLE.
Epistemonikos ID: 5fadb41050b1197144640e9d6f8f09c39859ed2f
First added on: May 05, 2024